In an interview that took place at the European Society for Medical Oncology 2024 Congress in Barcelona, Spain, Timothy Yap, MBBS, PhD, medical oncologist, The University of Texas…
Kidney cancer affects over 80,000 Americans annually, with renal cell carcinoma as the dominant type. Benjamin R. Lee, MD, MBA, outlines current AUA guideline recommendations, including when to…
HPV vaccination can prevent cervical cancer. Currently, there are two vaccines focused on this virus and its most dangerous types. Both are effective against HPV 16 and 18,…
The trial revealed a linear correlation between higher tumor burden and anti-PD1 and anti-programmed death ligand (PD-L1) checkpoint inhibitors, explained as the immune system responding to reactivation.
Virtually all cervical cancers are caused by the human papillomavirus (HPV). There are more than 200 HPV subtypes and at least 13 are carcinogenic. Two subtypes, HPV 16…
Bacillus Calmette-Guérin (BCG) is an effective biologic therapy widely used in patients with non-muscle invasive bladder cancer. Sanofi recently announced their intent to discontinue BCG production, leaving Merck…
Julio A. Aguirre-Ghiso, PhD, Professor of Medicine, Hematology, and Medical Oncology at the Tisch Cancer Institute Icahn School of Medicine at Mount Sinai, is leading a study on…
Neural networks (a.k.a. deep learning algorithms) can be used to teach computers to distinguish various types of disease via prior analysis of massive amounts of clinical data.
